⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6664987 | 0.78 | — | — | |
| SCHEMBL13180924 | 0.78 | — | — | |
| SCHEMBL7887917 | 0.76 | — | — | |
| SCHEMBL15459382 | 0.76 | — | — | |
| SCHEMBL13569499 | 0.76 | — | — | |
| SCHEMBL4367545 | 0.74 | — | — | |
| SCHEMBL37836 | 0.74 | — | — | |
| SCHEMBL5016586 | 0.74 | — | — | |
| SCHEMBL15031916 | 0.74 | — | — | |
| SCHEMBL16501322 | 0.74 | ALDH1A1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111936317-A | Method for producing strongly adherent (embossed) films on flexible substrates | 巴斯夫欧洲公司 | 2020-11-13 | — | — | CN | claimed |
| CN-111936315-A | Method for preparing strong adhesive liquid crystal film on flexible substrate | 巴斯夫欧洲公司 | 2020-11-13 | — | — | CN | claimed |
| WO-2023190758-A1 | COMPOSITE TUNGSTEN OXIDE PARTICLES, NEAR-INFRARED-ABSORBING PARTICLE DISPERSION LIQUID, AND NEAR-INFRARED-ABSORBING PARTICLE DISPERSION | 住友金属鉱山株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-20210292588-A1 | PROCESS FOR THE PRODUCTION OF STRONGLY ADHERENT LIQUID CRYSTAL FILMS ON FLEXIBLE SUBSTRATES | BASF SE (DE) | 2021-09-23 | — | — | US | disclosed |
| US-20210086545-A1 | PROCESS FOR THE PRODUCTION OF STRONGLY ADHERENT (EMBOSSED) FILMS ON FLEXIBLE SUBSTRATES | BASF SE (DE) | 2021-03-25 | — | — | US | disclosed |
| EP-2667850-A1 | MAINTAINING ANTIBODY-BINDING ACTIVITY OF IMMUNOSUPPRESSANT DRUG CONJUGATES | Siemens Healthcare Diagnostics Inc. (US) | 2013-12-04 | — | — | EP | disclosed |
| US-8334104-B2 | Methods for detection of hydrophobic drugs | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2012-12-18 | — | — | US | disclosed |
| US-20120237550-A1 | Maintaining Antibody-Binding Activity Of Immunosuppressant Drug Conjugates | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2012-09-20 | — | — | US | disclosed |
| WO-2012125856-A1 | MAINTAINING ANTIBODY-BINDING ACTIVITY OF IMMUNOSUPPRESSANT DRUG CONJUGATES | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2012-09-20 | — | — | WO | disclosed |
| EP-2489666-A2 | Chemically and chirally pure solifenacin base and its salts | Cadila Healthcare Limited (IN) | 2012-08-22 | — | — | EP | disclosed |
| EP-2484681-A1 | Chemically and chirally pure gentisate salt of solifenacin | Cadila Healthcare Limited (IN) | 2012-08-08 | — | — | EP | disclosed |
| US-20120064546-A1 | METHODS FOR DETECTION OF HYDROPHOBIC DRUGS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2012-03-15 | — | — | US | disclosed |
| US-20110136136-A1 | Methods For Detection Of Hydrophobic Drugs | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2011-06-09 | — | — | US | disclosed |
| US-7910378-B2 | Methods for detection of hydrophobic drugs | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2011-03-22 | — | — | US | disclosed |
| US-20100298371-A1 | PROCESS FOR PREPARING CHEMICALLY AND CHIRALLY PURE SOLIFENACIN BASE AND ITS SALTS | CADILA HEALTHCARE LIMITED (IN) | 2010-11-25 | — | — | US | disclosed |
| EP-2229387-A1 | PROCESS FOR PREPARING CHEMICALLY AND CHIRALLY PURE SOLIFENACIN BASE AND ITS SALTS | Cadila Healthcare Limited (IN) | 2010-09-22 | — | — | EP | disclosed |
| EP-2217926-A1 | METHODS FOR DETECTION OF HYDROPHOBIC DRUGS | Siemens Healthcare Diagnostics Inc. (US) | 2010-08-18 | — | — | EP | disclosed |
| WO-2009087664-A1 | PROCESS FOR PREPARING CHEMICALLY AND CHIRALLY PURE SOLIFENACIN BASE AND ITS SALTS | CADILA HEALTHCARE LIMITED (IN) | 2009-07-16 | — | — | WO | disclosed |
| WO-2009079374-A1 | METHODS FOR DETECTION OF HYDROPHOBIC DRUGS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2009-06-25 | — | — | WO | disclosed |
| US-20090155929-A1 | METHODS FOR DETECTION OF HYDROPHOBIC DRUGS | SIEMENS HEALTHCARE DIAGNOSTICS INC., A CORPORATION OF CALIFORNIA (US) | 2009-06-18 | — | — | US | disclosed |